Quinolinyl and benzothiazolyl ppargamma modulators

Details for Australian Patent Application No. 2001271637 (hide)

Owner Tularik Inc Japan Tobacco Inc.

Inventors McGee, Lawrence R; Hagiwara, Atsushi; Shinkai, Hisashi; Rubenstein, Steven M.; Furukawa, Noboru; Houze, Jonathan B.

Agent Spruson & Ferguson

Pub. Number AU-B-2001271637

PCT Pub. Number WO02/00633

Priority 60214810 28.06.00 US

Filing date 27 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 4 May 2006

International Classifications

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 215/12 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/36 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

4 May 2006 Application Accepted

  Published as AU-B-2001271637

31 August 2006 Standard Patent Sealed

21 February 2008 Assignment Registered

  Japan Tobacco Inc.; Tularik Inc The patent has been assigned to Amgen, Inc.; Japan Tobacco Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001271638

2001271636-Dual specificity antibodies and methods of making and using